Waddell & Reed Financial’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.72M | Sell |
|
|||||
|
2018
Q4 | $3.57M | Sell |
|
|||||
|
2018
Q3 | $32.9M | Sell |
|
|||||
|
2018
Q2 | $35.7M | Sell |
|
|||||
|
2018
Q1 | $98.5M | Sell |
|
|||||
|
2017
Q4 | $207M | Sell |
|
|||||
|
2017
Q3 | $294M | Buy |
|
|||||
|
2017
Q2 | $202M | Sell |
|
|||||
|
2017
Q1 | $248M | Sell |
|
|||||
|
2016
Q4 | $378M | Buy |
|
|||||
|
2016
Q3 | $302M | Buy |
|
|||||
|
2016
Q2 | $282M | Sell |
|
|||||
|
2016
Q1 | $355M | Sell |
|
|||||
|
2015
Q4 | $609M | Sell |
|
|||||
|
2015
Q3 | $541M | Buy |
|
|||||
|
2015
Q2 | $363M | Buy |
|
|||||
|
2015
Q1 | $267M | Buy |
|
|||||
|
2014
Q4 | $229M | Buy |
|
|||||
|
2014
Q3 | $190M | Sell |
|
|||||
|
2014
Q2 | $194M | Sell |
|
|||||
|
2014
Q1 | $222M | Buy |
|
|||||
|
2013
Q4 | $175M | Buy |
|
|||||
|
2013
Q3 | $124M | Buy |
|
|||||
|
2013
Q2 | $92.7M | Buy |
|